Evaluation of teledermatology during a pandemic: Assessing patient satisfaction, cost evaluation and clinical effectiveness

Australas J Dermatol. 2023 May;64(2):e185-e188. doi: 10.1111/ajd.14004. Epub 2023 Feb 18.

Z M Low¹, D N Koye², J Haurat³, B Ioppi⁴, E Antunes⁵, Timothy N Fazio^{5

6}, J Nicolopoulos¹, C Dolianitis^{1

6}, A Howard^{1

6}, B Radulski¹, L Scardamaglia^{1

6}, V Morgan^{1

6}, J S Kern^{1

6

7

8}

¹ Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
² Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
³ BioGRID Australia, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
⁴ Telehealth Unit, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
⁵ Health Intelligence Unit, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
⁶ Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
⁷ Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
⁸ Department of Dermatology, Alfred Hospital, Melbourne, Victoria, Australia.

No abstract available

Publication types